Crispr Therapeutics AG Financial Flexibility Index
Crispr Therapeutics AG financial flexibility index. Crispr Therapeutics AG (CRSP) has a Financial Flexibility Index of -0.12x as of March 2026. Free cash flow of $-108.39 Million (operating CF $-108.90 Million minus capex $504.00K) represents 0% of total liabilities ($911.26 Million). See CRSP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Crispr Therapeutics AG (2014–2025)
Financial flexibility index of Crispr Therapeutics AG from 2014 to 2025. Historical Financial Flexibility Index trend for Crispr Therapeutics AG across 12 annual periods. Check Crispr Therapeutics AG cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Crispr Therapeutics AG Financial Flexibility Index by Year (2014–2025)
Crispr Therapeutics AG financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Crispr Therapeutics AG. For the full cash flow conversion analysis, see how efficiently does Crispr Therapeutics AG generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-344.10 Million | $-345.01 Million | $343.43 Million | ▼ -120.5% |
| 2024 | -0.45x | $-140.87 Million | $-142.77 Million | $309.95 Million | ▲ +37.2% |
| 2023 | -0.72x | $-250.91 Million | $-260.38 Million | $346.77 Million | ▲ +42.0% |
| 2022 | -1.25x | $-458.55 Million | $-495.74 Million | $367.58 Million | ▼ -170.8% |
| 2021 | 1.76x | $620.68 Million | $538.97 Million | $352.42 Million | ▲ +231.1% |
| 2020 | -1.34x | $-220.01 Million | $-238.37 Million | $163.73 Million | ▼ -370.0% |
| 2019 | 0.50x | $63.36 Million | $56.68 Million | $127.33 Million | ▲ +151.5% |
| 2018 | -0.97x | $-93.47 Million | $-96.24 Million | $96.82 Million | ▼ -29.4% |
| 2017 | -0.75x | $-62.28 Million | $-70.10 Million | $83.51 Million | ▼ -59.9% |
| 2016 | -0.47x | $-52.29 Million | $-55.31 Million | $112.12 Million | ▼ -245.2% |
| 2015 | 0.32x | $60.58 Million | $59.43 Million | $188.55 Million | ▲ +175.1% |
| 2014 | -0.43x | $-3.64 Million | $-4.79 Million | $8.50 Million | — |